Veterinary Medicines

AMOXIVAL VET 400 mg tablets for dogs

Authorised
  • Amoxicillin trihydrate
Download as PDF

Product identification

Medicine name:
AMOXIVAL VET 400 mg tablets for dogs
Amoxival vet 400 mg Tablett
Active substance:
  • Amoxicillin trihydrate
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Amoxicillin trihydrate
    459.20
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01CA04
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Sweden
Available in:
  • Sweden
Package description:
  • (ID2) 200 Tablet: Box (Cardboard) with 20 Blister (PolyVinyl Chloride; Aluminium) each with 10 Tablet
  • (ID3) 20 Tablet: Box (Cardboard) with 2 Blister (PolyVinyl Chloride; Aluminium) each with 10 Tablet
  • (ID1) 10 Tablet: Box (Cardboard) with 1 Blister (PolyVinyl Chloride; Aluminium) with 10 Tablet

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Ceva Sante Animale
Marketing authorisation date:
Manufacturing sites for batch release:
  • Ceva Sante Animale
Responsible authority:
  • Swedish Medical Products Agency
Authorisation number:
  • 25059
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0164/002
Concerned member states:
  • Belgium
  • Denmark
  • Finland
  • Sweden
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."